Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial
Titel:
Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial
Auteur:
Cortes, Jorge Perl, Alexander E Döhner, Hartmut Kantarjian, Hagop Martinelli, Giovanni Kovacsovics, Tibor Rousselot, Philippe Steffen, Björn Dombret, Hervé Estey, Elihu Strickland, Stephen Altman, Jessica K Baldus, Claudia D Burnett, Alan Krämer, Alwin Russell, Nigel Shah, Neil P Smith, Catherine C Wang, Eunice S Ifrah, Norbert Gammon, Guy Trone, Denise Lazzaretto, Deborah Levis, Mark